AstraZeneca steps up push into cancer immunotherapy

July 31, 2014 2:32 PM

3 0

AstraZeneca steps up push into cancer immunotherapy

The company is seen as No. 4 in a race to develop the first drug in a new class that fights cancer by unleashing the body's immune system, behind rivals Roche, Merck & Co and Bristol-Myers Squibb.

But its MEDI4736 medicine is still viewed as a highly promising agent, both on its own and in combination with other treatments.

Read more

To category page

Loading...